Aloha

Cover Block

PUBLIC

Name	Aloha
Tagline	Patient engagement platform for healthcare practices
Headquarters	Irvine, California (relocated to Texas) [chiroeco.com]
Founded	2016
Business Model	SaaS
Industry	Healthtech
Technology	AI / Machine Learning
Geography	North America

Links

PUBLIC

• Website: https://getaloha.com
• LinkedIn: https://www.linkedin.com/company/getaloha

Executive Summary

PUBLIC

Aloha, formerly known as Review Wave, is a patient engagement platform that aims to automate core workflows for independent medical practices, a category where investor attention is warranted due to persistent operational fragmentation and high administrative overhead [getaloha.com]. The company was founded in 2016 and has since repositioned from a marketing automation tool to a broader platform, a transition marked by a rebrand and a headquarters relocation from Irvine, California to Texas [chiroeco.com, getaloha.com]. Its core offering bundles online scheduling, two-way texting, insurance verification, and digital forms into a single interface, with the stated goal of replacing a collection of disparate point solutions [getaloha.com].

Public records do not disclose the founding team's identities or backgrounds, leaving a material gap in assessing execution risk. The company's capitalization is similarly opaque, with no confirmed funding rounds, investors, or revenue metrics available in primary or secondary sources, suggesting a bootstrapped or privately financed path to date. Over the next 12-18 months, the key watchpoints are whether Aloha can translate its integrated feature set into documented customer traction and commercial scale, and if it can establish a clear technical or data advantage in a crowded market for practice management tools.

Data Accuracy: YELLOW -- Core company description and history corroborated by its own website and one trade publication; absence of team, funding, and traction data is consistent across sources.

Taxonomy Snapshot

Axis	Value
Founded	2016
Business Model	SaaS
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	North America

Company Overview

PUBLIC

Aloha operates as a patient engagement platform for healthcare practices, a business that appears to have evolved from a prior entity known as Review Wave. The company was founded in 2016 and was originally headquartered in Irvine, California, before relocating its operations to Texas at an unspecified date [chiroeco.com]. The rebrand from Review Wave to Aloha is a recent, undated development, positioned on its website as a unification of its offerings under a single brand [getaloha.com].

Public records show no formal funding rounds, named founders, or a detailed leadership team. The available footprint is limited to the company's own marketing materials and a handful of third-party directory listings, which primarily describe the product suite rather than corporate history. This suggests a bootstrapped or quietly funded operational model.

Key milestones are inferred from these sparse sources. The company's origin as Review Wave in 2016 marks its entry into the healthcare marketing and automation space. The headquarters move to Texas represents a strategic relocation, and the subsequent rebranding to Aloha signals an effort to present a consolidated, all-in-one platform beyond its initial review management focus [getaloha.com][chiroeco.com].

Data Accuracy: ORANGE -- Core company facts (founding year, rebrand, relocation) are cited from the company site and a trade publication, but team and funding details are absent from public databases.

Product and Technology

MIXED

Aloha positions itself as a comprehensive patient engagement platform, aiming to consolidate several administrative and communication workflows into a single SaaS application. According to the company's website, its core features are designed to automate the patient journey, covering functions from initial contact to retention [getaloha.com]. The public feature set includes online scheduling, two-way SMS texting, insurance verification, and digital intake forms, alongside analytics and unspecified AI tools [getaloha.com]. The platform's stated integration capability with leading practice management systems suggests a focus on interoperability within a clinic's existing tech stack, a common requirement for healthtech adoption [getaloha.com].

A notable public detail is the company's rebrand from Review Wave, and previously PracticePal, indicating an evolution in product focus over time. The current Aloha branding emphasizes an "all-in-one" approach, seeking to replace what it describes as fragmented point solutions [getaloha.com, thesurgepoint.com]. The AI component is mentioned but not detailed; without public case studies or technical documentation, its implementation and efficacy remain a feature claim rather than a demonstrated capability.

Data Accuracy: YELLOW -- Product claims are sourced solely from the company's website; no third-party reviews or technical validations were found.

Market Research

PUBLIC The patient engagement software market is a critical, expanding layer in the healthcare tech stack, driven by the persistent need for practices to improve operational efficiency and patient satisfaction amid rising administrative costs.

Market sizing for Aloha's specific segment is not publicly disclosed by the company or in third-party reports. The broader category of patient engagement platforms is often analyzed within the larger healthcare IT market. For context, analogous market research from Grand View Research valued the global patient engagement solutions market at $21.4 billion in 2023, projecting a compound annual growth rate (CAGR) of 17.6% from 2024 to 2030 [Grand View Research, 2024]. This growth is attributed to several demand drivers. The shift towards value-based care models, which tie reimbursement to patient outcomes and satisfaction, creates a direct financial incentive for practices to adopt tools that improve communication and adherence. Concurrently, patient expectations for digital, consumer-like experiences in healthcare continue to rise, pressuring traditional providers to modernize.

Key adjacent markets include practice management systems (PMS) and electronic health records (EHRs), which are often the primary systems of record that patient engagement platforms must integrate with. The success of Aloha's platform, as described on its website, hinges on its ability to connect with these incumbent systems to automate workflows that would otherwise be manual or managed through a patchwork of point solutions [getaloha.com]. Substitute markets are less about direct software competitors and more about the status quo: practices continuing to use front-desk staff for scheduling, phone calls for reminders, and paper forms for intake.

Regulatory and macro forces are significant. In the United States, regulations like the 21st Century Cures Act and its information-blocking rules push for greater patient data access and interoperability, which can enable platforms that facilitate patient communication. However, the healthcare sector's inherent complexity and strict compliance requirements, particularly around data privacy (HIPAA), create a high barrier to entry and ongoing operational overhead for any vendor in this space.

Metric	Value
Global Patient Engagement Solutions Market 2023	21.4 $B
Projected CAGR 2024-2030	17.6 %

The projected growth rate for the analogous broader market is substantial, indicating strong tailwinds for any platform that can demonstrate clear ROI by reducing administrative burden and improving patient retention. The absence of a defined SAM or SOM for Aloha, however, leaves the specific addressable opportunity within this large market unquantified based on public information.

Data Accuracy: YELLOW -- Market sizing is drawn from an analogous, third-party industry report. Specific segmentation for Aloha's niche is not confirmed.

Competitive Landscape

MIXED Aloha operates in a crowded and well-funded market for patient engagement software, where its primary challenge is establishing a distinct identity against a backdrop of established incumbents and specialized point solutions.

No named competitors were identified in the structured research, which complicates a direct feature-by-feature comparison. The competitive map for patient engagement platforms is typically divided into three tiers. The first tier consists of large, integrated practice management (PM) and electronic health record (EHR) systems like Epic, Cerner, and Athenahealth, which bundle patient communication tools directly into their core offerings, creating a high switching cost for existing customers. The second tier includes dedicated, best-of-breed patient engagement vendors such as Luma Health, Solutionreach, and Weave, which have raised significant venture capital to build comprehensive platforms focused on scheduling, messaging, and payments. The third tier comprises a long tail of specialized point solutions for specific functions like online reviews (BirdEye), telehealth (Doximity, Amwell), or forms (Phreesia). Aloha's stated value proposition of replacing fragmented tools suggests it is targeting the second and third tiers, aiming to be a unified alternative to using multiple single-point solutions.

Given the lack of public traction data, any defensible edge for Aloha is currently theoretical and based on its product claims. The platform's potential edge, if executed, would be its integration with leading practice management systems and its all-in-one suite combining scheduling, texting, insurance verification, and analytics [getaloha.com]. In a market where practices are often forced to cobble together several vendors, a truly smooth, integrated platform could reduce administrative overhead. However, this edge is highly perishable; it is a common claim among challengers, and durability would depend on achieving superior integration depth, user experience, and perhaps proprietary data workflows that are difficult to replicate. Without confirmed funding or a visible sales and marketing engine, Aloha's ability to build and sustain such an edge against well-capitalized rivals is unproven.

The company's most significant exposure is its lack of a clear moat in distribution, capital, or brand recognition. Established competitors own direct sales relationships with large practice groups and health systems, and many have built networks through partnerships with PM/EHR vendors. Furthermore, the rebrand from Review Wave to Aloha, while potentially signaling a product evolution, also introduces market confusion, as the name is shared with a prominent plant-based food brand [YouTube]. This creates a headwind for organic search and brand discovery. The most plausible 18-month scenario is one of continued niche operation. A winner in this segment would likely be a company that successfully bundles AI-driven automation into workflows at a compelling price point while expanding its distribution footprint. A challenger like Aloha could lose ground if it fails to secure the capital needed for product development and sales expansion, remaining a small, bootstrapped player in a localized market while larger, funded competitors continue to consolidate features and acquire market share.

Data Accuracy: YELLOW -- Competitive analysis is inferred from market structure; specific competitor claims and Aloha's market position are based solely on company marketing materials.

Opportunity

PUBLIC The potential outcome for Aloha is a single, integrated platform becoming the default operating system for patient-facing workflows in independent medical practices, a market where fragmentation and manual processes remain the norm.

The headline opportunity is Aloha becoming the category-defining, all-in-one patient engagement layer for the long-tail of independent clinics and group practices. This outcome is reachable not because of a novel technology, but because of a persistent market inefficiency: most practices still manage scheduling, reminders, forms, and insurance verification through a patchwork of disconnected tools, often supplemented by manual phone calls and paper [getaloha.com]. Aloha's proposition to consolidate these functions into one automated platform directly addresses a well-documented operational pain point. The evidence that this is more than an aspiration lies in the company's evolution from Review Wave, a marketing automation tool, into a broader engagement platform, suggesting a deliberate expansion into adjacent workflow areas based on observed customer needs [thesurgepoint.com]. The rebrand to Aloha positions it as a holistic solution rather than a point tool, which is the necessary first step toward category definition.

Growth would likely follow one of several concrete paths, each requiring a specific catalyst. The scenarios below outline plausible routes to scale.

Scenario	What happens	Catalyst	Why it's plausible
Vertical Dominance in Chiropractic & Dental	Aloha becomes the dominant patient engagement platform within specific high-adoption verticals like chiropractic or dental, where practice management software is often outdated.	A strategic partnership or deep integration with a leading Practice Management System (PMS) in one of these verticals.	The company's prior incarnation, Review Wave, specifically targeted chiropractors and moved its headquarters to Texas, a market with a high concentration of such practices, indicating existing domain focus and relationships [chiroeco.com].
The Embedded Workflow for PMS Vendors	Aloha's modules are white-labeled or deeply embedded into the platforms of larger practice management software vendors, becoming a de facto standard.	A formal OEM or technology partnership announced with a mid-market PMS player seeking to enhance its own feature set without rebuilding.	The company already claims integrations with leading practice management systems, a foundational requirement for this embedded strategy [getaloha.com]. This establishes technical feasibility and a potential commercial bridge.
Acquisition by a Practice Management Consolidator	Aloha is acquired by a larger healthcare IT roll-up or a major PMS vendor looking to quickly add a modern patient engagement suite to its portfolio.	Increased consolidation activity in the healthcare SaaS sector, driven by private equity or strategic buyers seeking growth.	The patient engagement software segment has seen consistent M&A activity as larger players seek to build comprehensive platforms. A bootstrapped, feature-complete company like Aloha represents a clean acquisition target.

What compounding looks like for Aloha is a classic land-and-expand flywheel within a medical practice. The initial wedge is often a single high-value module, such as automated review generation or online scheduling. Once integrated into a practice's daily workflow and connected to its PMS, the marginal cost and friction for the practice to adopt additional modules,like digital forms or insurance verification,drop significantly. Each new module increases daily user engagement (staff and patients), which in turn generates more data on patient behavior and practice efficiency. This data can be used to refine the AI tools the company mentions, creating a product improvement loop that makes the platform stickier and more valuable over time [getaloha.com]. Success in one practice within a local network or specialty can also serve as a powerful reference, unlocking adjacent practices through word-of-mouth, a critical sales channel in the fragmented healthcare provider market.

The size of the win, in a scenario where Aloha captures a meaningful share of its target niche, can be framed by looking at comparable transactions. Companies like Weave (patient communication for SMB healthcare) and Solutionreach (patient relationship management) were acquired for significant multiples, though specific figures are not publicly available for this analysis. A more direct indicator is the total addressable market for practice management and patient engagement software for small-to-midsize practices, which consistently measures in the tens of billions of dollars across various analyst reports. For a bootstrapped company with minimal known overhead, capturing even a single-digit percentage of a focused vertical sub-segment could translate to a company valued in the low hundreds of millions in an acquisition scenario (scenario, not a forecast). This represents a substantial return on the assumed internal capital invested, defining the upside potential that makes the company an object of analysis despite its thin public footprint. Data Accuracy: YELLOW -- Company claims from its website form the basis of the opportunity thesis; secondary source confirms prior focus on chiropractic vertical.

Sources

PUBLIC

1. [getaloha.com] Aloha Website | https://getaloha.com

2. [chiroeco.com] Review Wave, marketing automation for doctors, moves HQ to Texas | https://www.chiroeco.com/review-wave/

3. [thesurgepoint.com] Get Aloha Review 2026: Is It Better Than Review Wave? | https://www.thesurgepoint.com/blogs/get-aloha-review

4. [Grand View Research, 2024] Patient Engagement Solutions Market Size Report | https://www.grandviewresearch.com/industry-analysis/patient-engagement-solutions-market-report

5. [YouTube] ALOHA Plant-Based Brand Founder Interview | https://www.youtube.com/watch?v=f54jqEVgJi4